
zzso dominant zzso kidney disease zzso is the most common inherited kidney disease, accounting for up to zzso of patients on zzso replacement zzso There are presently no proven treatments for zzso and an effective zzso drug would have significant implications for patients and their zzso Since the identification of zzso and zzso there has been an explosion in knowledge identifying new disease mechanisms and testing new zzso Currently, the three major treatment strategies are to: zzso reduce zzso zzso zzso inhibit cell zzso and zzso reduce fluid zzso Several compounds shown to be effective in zzso models have already undergone clinical trials and more are zzso In addition, a whole raft of other compounds have been developed from zzso zzso The purpose of this paper is to evaluate the results of recent published trials, review current trials and highlight the most promising compounds in the zzso There appears to be no shortage of potential candidates, but several key issues need to be addressed to facilitate clinical zzso 

